What is the treatment and management for nephrolithiasis (kidney stones)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment and Management of Nephrolithiasis (Kidney Stones)

Increased fluid intake to achieve at least 2 liters of urine output daily is the first-line treatment for preventing kidney stone formation and recurrence. 1, 2, 3

Non-Pharmacological Management

Fluid Intake

  • Increase fluid intake to achieve at least 2-2.5 liters of urine output per day as the cornerstone of prevention 1, 2, 4
  • Balance fluid intake between day and night to avoid urinary supersaturation during nighttime 4
  • Water is the preferred fluid of choice, with no significant difference between tap water and mineral water 1, 5
  • Certain beverages like coffee, tea, wine, and orange juice may be associated with lower risk of stone formation 2
  • Avoid sugar-sweetened beverages and soft drinks acidified by phosphoric acid (colas) as they may increase stone risk 1, 2

Dietary Modifications

  • Maintain normal dietary calcium intake of 1,000-1,200 mg per day rather than restricting it, as calcium restriction can paradoxically increase stone risk by increasing urinary oxalate 2, 6
  • Consume calcium primarily with meals to enhance gastrointestinal binding of oxalate 2
  • Limit sodium intake to 2,300 mg daily to reduce urinary calcium excretion 2, 6
  • Reduce consumption of animal protein, which generates sulfuric acid that increases urinary calcium and reduces urinary citrate 2, 6
  • Limit dietary oxalate for patients with oxalate stones, avoiding foods like certain nuts, vegetables, wheat bran, chocolate, and tea 2, 6
  • Increase potassium intake through fruits and vegetables to increase urinary citrate excretion 2, 6
  • Limit vitamin C supplements as vitamin C can be metabolized to oxalate 2

Pharmacological Management

When to Initiate Pharmacotherapy

  • Offer pharmacologic therapy when increased fluid intake fails to reduce stone formation 7, 1, 2

Medication Selection Based on Stone Type and Metabolic Abnormalities

For Calcium Stones

  • Thiazide diuretics (hydrochlorothiazide, chlorthalidone, indapamide) for patients with hypercalciuria 1, 2, 3
  • Potassium citrate for patients with hypocitraturia or low urinary pH 1, 2, 8
  • Allopurinol for patients with hyperuricosuria and normal urinary calcium 1, 2

For Uric Acid Stones

  • Potassium citrate to increase urinary pH to 6.0-7.0 8
  • Allopurinol for patients with hyperuricosuria 2, 8

Dosing Guidelines for Potassium Citrate

  • For severe hypocitraturia (urinary citrate <150 mg/day): Start at 60 mEq/day (30 mEq twice daily or 20 mEq three times daily) 8
  • For mild to moderate hypocitraturia (urinary citrate >150 mg/day): Start at 30 mEq/day (15 mEq twice daily or 10 mEq three times daily) 8
  • Take with meals or within 30 minutes after meals or bedtime snack 8
  • Avoid doses greater than 100 mEq/day 8
  • Monitor serum electrolytes, creatinine, and complete blood counts every four months 8

Treatment Algorithm Based on Stone Type

Calcium Oxalate/Phosphate Stones (80% of all stones)

  1. First-line: Increase fluid intake to achieve 2L urine output daily 1, 2, 3
  2. Second-line (if fluid therapy fails):
    • For hypercalciuria: Thiazide diuretics 1, 2
    • For hypocitraturia: Potassium citrate 1, 2, 8
    • For hyperuricosuria: Allopurinol 1, 2

Uric Acid Stones

  1. First-line: Increase fluid intake to achieve 2L urine output daily 1, 3
  2. Second-line:
    • Potassium citrate to alkalinize urine (target pH 6.2-6.5) 8
    • Allopurinol for hyperuricosuria 2, 8

Infection (Struvite) Stones

  • Treat underlying urinary tract infection with appropriate antibiotics 9
  • Complete surgical eradication of stones is often necessary 9
  • Increase fluid intake to achieve 2L urine output daily 1, 4

Monitoring and Follow-up

  • Obtain 24-hour urine collections to assess metabolic abnormalities and guide therapy 2
  • Measure parameters including volume, pH, calcium, oxalate, uric acid, citrate, sodium, potassium, and creatinine 2
  • Monitor urinary citrate and/or pH every four months to evaluate treatment effectiveness 8
  • For patients on potassium citrate, monitor serum electrolytes, creatinine, and complete blood counts every four months 8

Common Pitfalls to Avoid

  • Restricting dietary calcium, which can paradoxically increase stone risk by increasing urinary oxalate 2, 6
  • Using sodium citrate instead of potassium citrate, as the sodium load can increase urinary calcium 2
  • Overreliance on calcium supplements rather than dietary calcium sources 2
  • Inadequate fluid intake, especially during periods of increased fluid loss (exercise, hot weather) 4, 6
  • Delaying treatment of urinary tract infections in patients with stones, which can lead to sepsis in obstructed systems 9

References

Guideline

Nephrolithiasis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Prevention of Calcium Oxalate Monohydrate Renal Stones

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Abnormal Urinalysis in Patients with Nephrolithiasis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Water and other fluids in nephrolithiasis: State of the art and future challenges.

Critical reviews in food science and nutrition, 2017

Research

Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2015

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of urinary tract infections associated with nephrolithiasis.

Current infectious disease reports, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.